UCB SA ADR (UCBJY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in UCB SA ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

UCB SA ADR (UCBJY) has returned 7.89% so far this year and 72.36% over the past 12 months. Looking at the last ten years, UCBJY has achieved an annualized return of 16.29%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Jun 18, 2009, UCBJY's average daily return is +0.07%, while the average monthly return is +1.46%. At this rate, your investment would double in approximately 4.0 years.

Historically, 50% of months were positive and 50% were negative. The best month was Feb 2024 with a return of +22.1%, while the worst month was May 2022 at -21.9%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 6 months.

On a daily basis, UCBJY closed higher 28% of trading days. The best single day was Nov 30, 2012 with a return of +19.1%, while the worst single day was Mar 13, 2020 at -20.1%.

UCB SA ADR has an annualized alpha of 17.15%, beta of 0.21, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since June 19, 2009.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (75.20%) than losses (44.18%) — typical of diversified or defensive assets.
• Beta of 0.21 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

UCBJY ranks 89 for risk / return — in the top 89% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for UCB SA ADR (UCBJY) and compare them to a chosen benchmark (S&P 500 Index).

UCB SA ADR provided a 0.52% dividend yield over the last twelve months, with an annual payout of $0.79 per share.

The table displays the monthly dividend distributions for UCB SA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the UCB SA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the UCB SA ADR was 50.32%, occurring on Sep 22, 2022. Recovery took 399 trading sessions.

The current UCB SA ADR drawdown is 10.35%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of UCB SA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how UCB SA ADR is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.